The pursuit of outperformance leads many investors to carefully choose individual stocks. Picking the right ones can be a game-changer for growing your wealth.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The closing price of Sana Biotechnology Inc (NASDAQ: SANA) was $4.28 for the day, up 0.23% from the previous closing price of $4.27. In other words, the price has increased by $0.23 from its previous closing price. On the day, 1.2 million shares were traded. SANA stock price reached its highest trading level at $4.445 during the session, while it also had its lowest trading level at $4.245.
Ratios:
Our analysis of SANA’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 5.20 and its Current Ratio is at 5.20. In the meantime, Its Debt-to-Equity ratio is 0.29 whereas as Long-Term Debt/Eq ratio is at 0.26.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Rodman & Renshaw on June 26, 2024, initiated with a Buy rating and assigned the stock a target price of $16.
On January 16, 2024, H.C. Wainwright Upgraded its rating to Buy which previously was Neutral but kept the price unchanged to $12.
On September 25, 2023, JMP Securities started tracking the stock assigning a Mkt Outperform rating and target price of $9.JMP Securities initiated its Mkt Outperform rating on September 25, 2023, with a $9 target price.
Insider Transactions:
Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Sep 24 ’24 when Mulligan Richard sold 150,000 shares for $4.08 per share. The transaction valued at 612,570 led to the insider holds 2,848,121 shares of the business.
Mulligan Richard sold 150,000 shares of SANA for $583,170 on Sep 25 ’24. The Director now owns 2,698,121 shares after completing the transaction at $3.89 per share. On Sep 25 ’24, another insider, RICHARD MULLIGAN, who serves as the Director of the company, bought 150,000 shares for $4.09 each.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, SANA now has a Market Capitalization of 952154496 and an Enterprise Value of 799068224.
Stock Price History:
Over the past 52 weeks, SANA has reached a high of $12.00, while it has fallen to a 52-week low of $2.74. The 50-Day Moving Average of the stock is -17.68%, while the 200-Day Moving Average is calculated to be -36.27%.
Shares Statistics:
SANA traded an average of 1.69M shares per day over the past three months and 1729760 shares per day over the past ten days. A total of 197.86M shares are outstanding, with a floating share count of 121.78M. Insiders hold about 45.39% of the company’s shares, while institutions hold 51.05% stake in the company. Shares short for SANA as of 1726185600 were 31169232 with a Short Ratio of 18.44, compared to 1723680000 on 31711043. Therefore, it implies a Short% of Shares Outstanding of 31169232 and a Short% of Float of 29.07.
